Craneware

CRW · AIM · Health Care · mcap £377m · 1100.0p

Craneware sells cloud software and data analytics, under the Trisus platform, that help US hospitals manage pricing, billing, drug-discount compliance and costs. Revenue is mostly recurring subscriptions.

Target	Promise	Said	Status
2024
17 Jan 2024	Continue share buyback to 17 January 2024 under same terms	17 Oct 2023	✓ Kept
	“extend the share buyback programme, originally due to expire on 17 October 2023, for a further three months to 17 January 2024, under the same terms as previously announced” Result Buyback was extended again in April 2024 to July. 16 Apr 2024 · Extension of share buyback programme
31 Jul 2024	Make first Trisus applications available on Microsoft marketplace in July 2024	2 Jul 2024	✓ Kept
	“The first of the Trisus applications to be made available on the Microsoft commercial marketplace in July 2024 will be Trisus Chargemaster, Trisus Decision Support, and Trisus Labor Productivity.” Result Later updates describe joint marketing with Microsoft and Oracle; no sign of delay. “the first major customer contract secured via the Microsoft Azure Marketplace”13 Jan 2025 · H1 FY25 Trading Update
2025
30 Jun 2025	Deliver FY25 results in line with market expectations	13 Jan 2025	✓ Kept
	“The Board remains confident in its outlook for FY25 and expects to deliver results for the year ending 30 June 2025 in line with current market expectations” Also stated 11 Mar 2025 Result July 2025 update said results were ahead of expectations; EBITDA $65.3m. “Subject to audit, the Board expects a 12% increase in adjusted EBITDA1 to over $65m (FY24: $58.3m) delivered by revenue growth of 9% to $205.7m (FY24: $189.3m).”16 Jul 2025 · FY25 Trading Update